Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Study status updated to Completed with actual completion date 2025-10-30 and last update posted 2025-11-20. Principal investigator changed from Jad Cuahoud, MD to Jon Chatzkel, MD.
    Difference
    0.5%
    Check dated 2025-11-25T21:22:14.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added branding for the Moffitt Cancer Center Clinical Trials website and a 'Helpful Links Provided by' section. Removed the government funding status notice.
    Difference
    0.6%
    Check dated 2025-11-18T19:03:35.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The changes are limited to visual/layout adjustments and minor metadata updates; no core study information appears to be modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T23:01:28.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now includes newer date references (October 2025) and an 'Estimated Last Update Posted' item, while removing earlier June 2025 dates. This signals an update to the page's recency and last-update messaging.
    Difference
    0.5%
    Check dated 2025-10-20T20:26:00.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added a government operations status notice and updated the version to v3.2.0; removed the v3.1.0 version reference.
    Difference
    3%
    Check dated 2025-10-06T13:57:34.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Updated revision from v3.0.2 to v3.1.0, indicating a new version release with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T09:46:35.000Z thumbnail image

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.